Pharma companies likely to post subdued performance in Q2 FY17: Report

摘要

Domestic pharmaceutical companies are likely to report subdued sales, EBITDA and net profit figures in the second quarter of this fiscal, even as the formulations business may see a strong recovery, a report said.